MYH1

Chr 17

myosin heavy chain 1

Also known as: HEL71, MYHSA1, MYHa, MyHC-2X/D, MyHC-2x

Myosin heavy chain 1 is a contractile protein that converts chemical energy into mechanical energy through ATP hydrolysis and is required for normal hearing by regulating outer hair cell electromotility in the cochlea. Mutations cause autosomal dominant hearing loss disorders. This gene shows extremely high constraint against loss-of-function variants, indicating that such mutations are typically not tolerated.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.08
Clinical SummaryMYH1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
1 unique Pathogenic / Likely Pathogenic· 97 VUS of 100 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.08LOEUF
pLI 0.000
Z-score 0.85
OE 0.91 (0.771.08)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.04Z-score
OE missense 1.00 (0.951.05)
1027 obs / 1030.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.91 (0.771.08)
00.351.4
Missense OE1.00 (0.951.05)
00.61.4
Synonymous OE1.11
01.21.6
LoF obs/exp: 91 / 100.2Missense obs/exp: 1027 / 1030.2Syn Z: -1.73
DN
0.82top 10%
GOF
0.6444th %ile
LOF
0.3356th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

100 submitted variants in ClinVar

Classification Summary

Pathogenic1
VUS97
Likely Benign2
1
Pathogenic
97
VUS
2
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
1
0
1
Likely Pathogenic
0
0
0
0
0
VUS
0
95
0
2
97
Likely Benign
0
2
0
0
2
Benign
0
0
0
0
0
Total09712100

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MYH1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC